EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial

Ashley M Nelson, Daniel Yang, Annemarie D Jagielo, Jennifer D'Alotto, Cathleen Poliquin, Dustin J Rabideau, Katherine G Cronin, Richard A Newcomb, Yi-Bin Chen, Zachariah DeFilipp, Joseph A Greer, Areej El-Jawahri und 1 weitere

Journal of the National Comprehensive Cancer Network · 2024-02 · 22 (1) · 34-42

DOI: 10.6004/jnccn.2023.7080 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-02. Verfasst von Ashley M Nelson und 12 weiteren Autor:innen. Beteiligte Einrichtung: 1Massachusetts General Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Bronchiolitis Obliterans Syndrome, Graft vs Host Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

More than half the long-term survivors of allogeneic hematopoietic cell transplantation develop chronic graft-versus-host disease (GVHD), a debilitating inflammatory syndrome. Supportive interventions to assist survivors in coping with chronic GVHD are critically needed. Patients and Methods: We conducted a pilot randomized clinical trial of a multidisciplinary group intervention (Horizons Program; n=39) versus minimally enhanced usual care (n=41) for patients with moderate or severe chronic GVHD. Horizons participants received 8 weekly sessions about GVHD and coping co-led by a transplant clinician and a behavioral health expert via a secure videoconferencing platform. Participants completed the following surveys before randomization, at 10 weeks, and at 18 weeks: Functional Assessment of Cancer Therapy–Bone Marrow Transplant Scale (FACT-BMT) for quality of life (QoL), Lee Symptom Scale for symptom burden, and Hospital Anxiety and Depression Scale–Depression Symptoms (HADS) for mood. The primary endpoint was feasibility (≥50% enrollment, ≥80% attendance in half the sessions for the Horizons arm only, and ≥80% retention). We also explored preliminary efficacy of the Horizons intervention on changes in patient-reported outcomes with linear mixed effects models and estimates of effect size at 10 weeks.

Results

We enrolled and registered 80 (67.2%) of 119 eligible patients (mean age, 62 years; 48.8% female). Of the participants in the Horizons Program, 84.6% attended at least half the sessions. Of registered participants, 91.3% completed assessment follow-ups (Horizons, 35/39 [89.7%]; minimally enhanced usual care, 38/41 [92.7%]). Horizons participants reported improvements in QoL ( b = 2.24; d =0.53), anxiety symptoms ( b = –0.10; d =0.34), and depression symptoms ( b = –0.71; d =0.44) compared with participants who received minimally enhanced usual care.

Conclusions

Participation in a multidisciplinary group intervention study was feasible for patients with chronic GVHD, with promising signals for improving QoL and mood. A full-scale efficacy trial is needed to confirm effects on patient-reported outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchiolitis Obliterans SyndromeGraft vs Host DiseaseHumansFemaleMiddle AgedMaleQuality of LifePilot ProjectsAdaptation, Psychological

Stichwörter der Autor:innen

Feasibility StudiesGraft vs Host DiseasePsychosocial InterventionQuality of LifeRandomized Controlled Trial

Autor:innen und Institutionen

  • 1Massachusetts General Hospital, Boston, Massachusetts.
  • 2Harvard Medical School, Boston, Massachusetts.
  • 3University of Miami, Coral Gables, Florida.

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS

Zitieren

APA

Nelson, A. M., Yang, D., Jagielo, A. D., D'Alotto, J., Poliquin, C., Rabideau, D. J., Cronin, K. G., Newcomb, R. A., Chen, Y. B., DeFilipp, Z., Greer, J. A., El-Jawahri, A., & Traeger, L. (2024). Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial. Journal of the National Comprehensive Cancer Network, 22(1), 34-42. https://doi.org/10.6004/jnccn.2023.7080

Vancouver

Nelson AM, Yang D, Jagielo AD, D'Alotto J, Poliquin C, Rabideau DJ, et al. Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial. Journal of the National Comprehensive Cancer Network. 2024;22(1):34-42. doi:10.6004/jnccn.2023.7080

BibTeX
@article{Nelson2024,
  author = {Nelson, Ashley M and Yang, Daniel and Jagielo, Annemarie D and D'Alotto, Jennifer and Poliquin, Cathleen and Rabideau, Dustin J and Cronin, Katherine G and Newcomb, Richard A and Chen, Yi-Bin and DeFilipp, Zachariah and Greer, Joseph A and El-Jawahri, Areej and Traeger, Lara},
  title = {Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  volume = {22},
  number = {1},
  pages = {34--42},
  doi = {10.6004/jnccn.2023.7080}
}
Kostenlos starten →